Lupin partners with Celnova Pharma to distribute NaMuscla in Argentina and Colombia
NaMuscla (mexiletine) to be commercialised for the treatment of non-dystrophic myotonic disorders in adults
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Mexiletine
US FDA grants Lupin’s Mexiletine Orphan Drug Designation
Myotonic disorders are a group of heterogeneous, inherited, neuromuscular disorders characterized by a shared symptom called…